Fidelity Investments’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.36M | Sell |
181,626
-80,384
| -31% | -$1.05M | ﹤0.01% | 2434 |
|
2025
Q1 | $2.77M | Sell |
262,010
-186,801
| -42% | -$1.98M | ﹤0.01% | 2344 |
|
2024
Q4 | $7.62M | Buy |
448,811
+5,803
| +1% | +$98.5K | ﹤0.01% | 2028 |
|
2024
Q3 | $10.3M | Sell |
443,008
-112,516
| -20% | -$2.61M | ﹤0.01% | 1914 |
|
2024
Q2 | $13.5M | Sell |
555,524
-66,334
| -11% | -$1.62M | ﹤0.01% | 1779 |
|
2024
Q1 | $21M | Sell |
621,858
-242,500
| -28% | -$8.19M | ﹤0.01% | 1634 |
|
2023
Q4 | $27.3M | Sell |
864,358
-75,923
| -8% | -$2.39M | ﹤0.01% | 1508 |
|
2023
Q3 | $24M | Buy |
940,281
+74,081
| +9% | +$1.89M | ﹤0.01% | 1517 |
|
2023
Q2 | $24.8M | Buy |
866,200
+37,808
| +5% | +$1.08M | ﹤0.01% | 1555 |
|
2023
Q1 | $19.9M | Sell |
828,392
-81,851
| -9% | -$1.96M | ﹤0.01% | 1610 |
|
2022
Q4 | $15.4M | Sell |
910,243
-44,082
| -5% | -$748K | ﹤0.01% | 1720 |
|
2022
Q3 | $14.1M | Buy |
954,325
+33,568
| +4% | +$497K | ﹤0.01% | 1750 |
|
2022
Q2 | $14.5M | Sell |
920,757
-39
| -0% | -$614 | ﹤0.01% | 1785 |
|
2022
Q1 | $24.8M | Buy |
920,796
+272
| +0% | +$7.33K | ﹤0.01% | 1693 |
|
2021
Q4 | $34.1M | Sell |
920,524
-152,453
| -14% | -$5.64M | ﹤0.01% | 1574 |
|
2021
Q3 | $51.3M | Buy |
1,072,977
+342,687
| +47% | +$16.4M | ﹤0.01% | 1400 |
|
2021
Q2 | $24.7M | Hold |
730,290
| – | – | ﹤0.01% | 1756 |
|
2021
Q1 | $30.2M | Hold |
730,290
| – | – | ﹤0.01% | 1617 |
|
2020
Q4 | $31.7M | Sell |
730,290
-39,710
| -5% | -$1.72M | ﹤0.01% | 1502 |
|
2020
Q3 | $33M | Buy |
770,000
+95,000
| +14% | +$4.08M | ﹤0.01% | 1357 |
|
2020
Q2 | $31.6M | Buy |
675,000
+275,000
| +69% | +$12.9M | ﹤0.01% | 1357 |
|
2020
Q1 | $5.44M | Hold |
400,000
| – | – | ﹤0.01% | 1913 |
|
2019
Q4 | $4.35M | Hold |
400,000
| – | – | ﹤0.01% | 2084 |
|
2019
Q3 | $4.11M | Buy |
+400,000
| New | +$4.11M | ﹤0.01% | 2102 |
|